Takeda Pharmaceutical (TAK) Shares Outstanding (Weighted Average) (2017 - 2026)

Takeda Pharmaceutical's Shares Outstanding (Weighted Average) history runs 10 years deep, the most recent figure standing at $10810.0 for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) fell 2.68% year-over-year to $10810.0; the TTM figure through Mar 2026 stood at $10810.0 (down 2.68% YoY), while the FY2026 annual figure was $11262.0, up 1.23% from the prior year.
• Shares Outstanding (Weighted Average) was $10810.0 for Q1 2026 at Takeda Pharmaceutical, up from $0.89 in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $11.3 billion in Q1 2024 to a low of $0.18 in Q3 2023.
• Historically, Shares Outstanding (Weighted Average) has averaged $667.0 million across 5 years, with a median of $0.89 in 2025.
• Biggest YoY gain for Shares Outstanding (Weighted Average) was 3003099.81% in 2025; the steepest drop was 100.0% in 2025.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $1.3 in 2022, then slumped by 51.21% to $0.64 in 2023, then jumped by 38.16% to $0.88 in 2024, then climbed by 1.45% to $0.89 in 2025, then soared by 1211477.51% to $10810.0 in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $10810.0 (Q1 2026), $0.89 (Q4 2025), and $11501.9 (Q3 2025), per Business Quant data.